In this study, the reversion of ERBIN silencing by EPIC-0412 is only one of all the effects, but all of EPIC's mechanisms of action are based on tumor epigenomics, which reveals the important role of epigenetic reprogramming in GBM cells in mediating cell tumor proliferation, chemotherapy resistance, and metabolic reprogramming. This evidence concerns the gene ERBIN and neoplasm.